Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Avoid Fisker Stock Even After the Spartan Energy Merger

Fisker's SPAC merger has closed, and FSR stock rallied on the news. But the slide ahead of the merger shouldn't be ignored.

Why Is Naked Brand Group Still on Nasdaq?

Like a guest who won't leave the party, Naked Brand Group has stuck around the Nasdaq too long. It's time for NAKD stock to exit the party.

General Electric Only Looks Bullish From a Superficial Angle

With air travel improving from this year’s bottom, you might be tempted to buy GE stock. Here’s why that’s not a good idea.

Pinterest Stock Catapulted for Valid Reasons, but Note the Valuation

Pinterest's recent earnings data are undeniably positive. Yet, the market's reaction might have been overdone as PINS stock is pricey now.

Chesapeake Energy Stock Is Worthless Now Before Chapter 11 Ends

Do not buy Chesapeake Energy stock - it is now completely 100% worthless. There is no chance that existing Chesapeake Energy stock owners will have any new shares in the company after Chapter 11.

5 Industries Biden Would Destroy as President

If Joe Biden wins on Election Day, election stocks in these five industries could hit bad times: Coal, Cruise Lines, Oil and Gas, Pharmaceuticals, Ride Sharing. Tread carefully as voters head to the polls.

8 Stocks and Sectors That Will Lose Their Shine on Wall Street

The world will change in the next 10 years, as it has in the last 10. For these stocks and sectors, change is unlikely to be for the better.

Investors in Luckin Stock Need to Wake up and Smell the Coffee

Months after China's answer to Starbucks endured an accounting scandal and found its stock delisted from the NASDAQ stock exchange, the company's share price has more than doubled. While that increase might be great for some investors, Luckin stock remains too risky a bet for long-term investors to consider buying at this point.

With the Pandemic Peaking, Hold Off on United Airlines Stock

While it is introducing rapid testing for the novel coronavirus, a potential winter surge leaves United Airlines stock's prospects uncertain.

4 Stocks to Sell Before the Bear Market Comes

Retail investors are looking for stocks to sell as the second Covid-19 wave threatens to wipe up a sizable chunk of the markets again.

Accounting Misdirection Could Send Array Technologies Stock Falling 50%

Array Technologies stock will drop 50% unless the company can extend innovation from its accounting department to its engineering one.

Exxon Mobil Stock Is Becoming Increasingly Irrelevant by the Day

With Americans seemingly favoring Joe Biden, the political environment doesn’t favor XOM stock. But even if Trump wins reelection, the calls for cleaner energy will not die.

While There’s Light In Sight, General Electric Remains Risky

GE stock crushed expectations in a third quarter earnings report. But lingering fraud allegations and pension woes must be addressed.

Despite Covid-19 Surge, Sit Things Out With XpresSpa Stock

With novel coronavirus cases on the rise again, can XpresSpa stock make a comeback? It's debatable, so sit out on this pandemic play.

There’s No Proof Yet That Luckin Coffee Deserves Investment

Without accurate numbers and proof it has been reformed, don’t be too eager to put your money into questionable Luckin stock.

3 Car Stocks to Leave on the Lot as Americans Drive Less

Strict social distancing and stay-at-home regulation are hammering car stocks, but these companies are faring worse than the industry.

Not a Pretty Picture, Kodak Stock Looks Like a Really Risky Bet Right Now

Kodak stock declines as allegations surrounding the company’s questionable actions prior to the loan announcement continue to swirl. Here’s why KODK stock is a risky investment.

Avoid Inovio Pharmaceuticals Stock Until the FDA Greenlights Trials

While I’d like to tell you Inovio Pharmaceuticals is a blood-in-the-streets opportunity, I can’t. Avoid INO stock for now.

Cloudflare Looks Overvalued Amid Threat From Fastly

In a development that could hurt NET stock down the road, highly innovative Fastly is taking steps to improve its IT security capabilities,